liraglutide
NN2211-4315
Phase 3 small_molecule completed
Quick answer
liraglutide for Diabetes is a Phase 3 program (small_molecule) at Novo Nordisk A/S with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Diabetes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed